| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 1,762,000 | 1,702,000 | | Cost of Revenue | 813,000 | 786,000 | | | Gross Profit | 949,000 | 916,000 | | | Operating Expenses | | Research Development | 108,000 | 126,000 | | Selling General and Administrative | 508,000 | 470,000 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 333,000 | 320,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 2,000 | | Earnings Before Interest And Taxes | 338,000 | 322,000 | | Interest Expense |
-
|
-
| | Income Before Tax | 338,000 | 322,000 | | Income Tax Expense | 88,000 | 122,000 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 250,000 | 200,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 250,000 | 200,000 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $250,000 | $200,000 |
|
0.34% Nasdaq 0.00%
Income Statement
